Inclusion Criteria:~* Patient meets clinical criteria for prodromal Alzheimer's disease (MMSE 24-30)~* Memory
complaint by subject or study partner~* CSF aÎ²42 levels < 200pg/mL or Total Tau/aÎ²42 ratio of ≥ 0.39~* Score
of ≤4 on the Modified Hachinski Ischemia Scale~* CT results consistent with Alzheimer's disease~* Medically
stable~* 6 years education~* Reliable study partner~* Must be able to swallow capsules~
